09.08.2021
Improve Outcomes
$3,489,763.00
42 months
Development of novel Glucose Responsive Glucagon (GRG) delivery system for the prevention of hypoglycemia for people with T1D
Development of an implantable glucose responsive glucagon delivery system for the prevention of hypoglycemia for people with T1D